Genesis IBRC Fair Value
Genesis IBRC fair value. Genesis IBRC (GENESIS) average fair value is ₹15.04 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹85.36 (-82.39%), fair value range ₹7.69–₹22.38. For live price and a broader fundamental view, visit Genesis IBRC share price chart.
Fair Value Analysis Export
GENESIS Fair Value vs Current Price — Valuation Summary
GENESIS average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Explore GENESIS true value to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Asset-Based Valuation
GENESIS Fair Value Analysis — Data Sources & Coverage
Genesis IBRC financial data sources, valuation methods applied and sector benchmarks used. Check Genesis IBRC marketcap in USD to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
GENESIS vs Healthcare Sector Peers — P/E, P/B & Market Cap
Genesis IBRC P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Emcure Pharmaceuticals | EMCURE | 35.85 | 7.38 | ₹37,156 |
| Syngene International | SYNGENE | 68.69 | 3.13 | ₹15,000 |
| Sat Kartar Life | SATKARTAR | 16.56 | 4.14 | ₹307 |
| Divis Laboratories | DIVISLAB | 87.22 | 15.22 | ₹253,522 |
| Aurobindo Pharma | AUROPHARMA | 25.97 | 2.54 | ₹96,479 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.